How to Remove SARS-CoV-2 Virus Spike Protein From Body?

As concerns about COVID-19 continue, many individuals are seeking information on how to remove spike protein from their bodies. While vaccines have been instrumental in controlling the spread of the virus, some people may wonder if there are natural or medical ways to remove spike protein from their systems. In this research-based article, we will explore what spike proteins are, their role in COVID-19, and discuss potential methods to remove them from the body.

Spike proteins on the surface of the SARS-CoV-2 virus facilitate the virus’s entry into human cells. These proteins bind to receptors on human cells, enabling the virus to fuse with the cell membrane and gain access to the host cell. This interaction is the initial step in the viral infection process.

Structural Insights: Spike Proteins and Vaccine Development

Structurally, spike proteins, especially the receptor-binding domain (RBD) of the S1 subunit, have garnered significant attention due to their critical role in viral entry via binding to the Angiotensin Converting Enzyme II (ACE2) receptor. This understanding has driven vaccine development strategies aimed at inhibiting RBD-ACE2 binding and preventing viral entry.

Which cells produce spike protein after COVID vaccine?

Human cells do not produce the spike protein in COVID-19 vaccines, such as Pfizer-BioNTech and Moderna vaccines, which are based on messenger RNA (mRNA) technology. The body synthesizes the spike protein synthetically after vaccination.

Here’s how it works:

Vaccination: When you receive a COVID-19 mRNA vaccine, the vaccine contains a small piece of genetic material known as messenger RNA (mRNA). This mRNA carries the genetic code for a portion of the spike protein found on the surface of the SARS-CoV-2 virus, which causes COVID-19.

Cell Uptake: Human cells, typically muscle cells at the injection site, take up the mRNA after vaccination.

mRNA Translation: Inside these cells, the ribosomes read the mRNA and use it as a blueprint to build a fragment of the spike protein.

Spike Protein Production: Cells release this newly synthesized spike protein fragment into the bloodstream.

Immune Response: The immune system recognizes these spike protein fragments as foreign invaders and produces antibodies against them. These antibodies help the immune system remember the spike protein and stand ready to neutralize the virus in later exposure.

It’s important to note that the spike protein produced in this process is a harmless fragment, not the entire virus. It cannot replicate, and it does not cause COVID-19. It serves as a way to train the immune system to recognize and respond to the spike protein, which is a crucial part of the SARS-CoV-2 virus.

What is the Role of Spike Proteins in Covid 19?

The spike protein in COVID-19, also known as the SARS-CoV-2 virus’s spike glycoprotein, plays a pivotal role in the infection process. Its primary function is to facilitate the virus’s entry into human cells. Here’s an overview of the role of spike proteins in COVID-19:

Attachment to Host Cells

The spike protein’s initial role is to bind to specific receptors on the surface of human cells. In the case of SARS-CoV-2, the primary receptor is the angiotensin-converting enzyme 2 (ACE2) receptor, which is present on the surface of many human cells, particularly in the respiratory tract and other tissues.

Fusion and Entry

After attaching to the ACE2 receptor, the spike protein undergoes structural changes. These changes enable the virus to fuse with the host cell membrane, allowing the virus’s genetic material (RNA) to enter the host cell.

Replication and Spread

Once inside the host cell, the viral RNA serves as a template for the replication and transcription of new viral particles. The host cell’s machinery is hijacked to produce more virus particles. These newly formed virus particles can then infect neighboring cells, propagating the infection.

Immune Evasion

The spike protein is also involved in immune evasion. It can undergo mutations, leading to the emergence of new variants of the virus. Some of these variants may have changes in the spike protein that allow the virus to evade the immune response, potentially leading to increased transmissibility or resistance to immunity developed from previous infections or vaccinations.

Target of Vaccines

Importantly, the spike protein is the primary target of most COVID-19 vaccines. Vaccines like those developed by Pfizer-BioNTech, Moderna, AstraZeneca, Johnson & Johnson, and others contain synthetic or inactivated versions of the spike protein or the genetic instructions (mRNA) to produce it. When a person is vaccinated, their immune system is exposed to the spike protein or its genetic code, allowing it to develop antibodies and immune memory specific to the spike protein.

Immune Response

The presence of antibodies against the spike protein is essential because it enables the immune system to recognize and neutralize the spike protein when the actual virus enters the body. This immune response can prevent the virus from attaching to host cells and initiating an infection.

Why Removing Spike Proteins Matters

Understanding the significance of spike proteins in COVID-19 is crucial. They play a pivotal role in the pathogenesis of the disease. Spike proteins are the target of most COVID-19 vaccines, which stimulate the immune system to produce antibodies against them. These antibodies help protect individuals from severe illness by neutralizing the virus before it can infect their cells. Therefore, the presence of spike proteins in the body can be both a sign of an active infection and an indicator of immunity.

Adverse Events and Safety Signals

Compared to other vaccines, COVID-19 vaccines have displayed a higher adverse event rate. Histopathological findings and autopsies of individuals who passed away post-vaccination have supported the vaccine’s role in vascular-related events, most frequently associated with myocardial complications.

While the spike protein itself is not inherently harmful, certain adverse effects and concerns related to it have arisen, primarily in the context of COVID-19 vaccination and viral infection. It’s essential to understand these issues in a balanced manner:

Vaccination-Related Adverse Effects:

a. Local Reactions: Some individuals who receive COVID-19 vaccines, particularly mRNA vaccines like Pfizer-BioNTech and Moderna, may experience mild to moderate local reactions at the injection site, including pain, redness, or swelling. These reactions are generally short-lived and are signs of the body’s immune response.

b. Systemic Reactions: Vaccinated individuals may also experience systemic reactions within a few days after vaccination. These can include fatigue, headache, muscle pain, chills, fever, or nausea. These reactions are usually mild to moderate and indicate that the immune system is responding to the vaccine.

c. Myocarditis and Blood Clotting: There have been rare reports of myocarditis (inflammation of the heart muscle) and blood clotting disorders following COVID-19 vaccination. These events are being closely monitored and investigated. It’s important to note that the risk of these adverse effects is still much lower than the risk of severe complications from COVID-19 itself.

Concerns About Spike Protein Persistence:

Some studies have suggested that the spike protein produced by the mRNA vaccines may persist in the bloodstream and tissues for a period after vaccination. However, the clinical significance of this persistence and whether it has adverse effects is still being studied. It’s essential to differentiate between spike protein fragments generated by vaccination and the entire virus, as the former is not infectious.

Variants and Immune Evasion:

SARS-CoV-2 variants with mutations in the spike protein have raised concerns about immune evasion. These variants may partially escape immunity acquired through prior infection or vaccination, potentially leading to reinfections or reduced vaccine effectiveness. However, vaccines remain effective at preventing severe illness and hospitalization, even against some variants.

Allergic Reactions:

In rare instances, individuals may experience severe allergic reactions (anaphylaxis) after receiving COVID-19 vaccines. While the exact cause is still under investigation, it’s essential to consider potential allergenic components, including polyethylene glycol (PEG), which is found in the lipid nanoparticles used in some vaccine formulations.

Thrombosis with Thrombocytopenia Syndrome (TTS):

Certain adenovirus vector-based COVID-19 vaccines, like AstraZeneca and Johnson & Johnson’s Janssen vaccine, have been associated with an extremely rare but serious adverse event called Thrombosis with Thrombocytopenia Syndrome (TTS). This condition involves unusual blood clotting and low platelet levels.

Future Research and Monitoring:

The adverse effects related to the spike protein are subjects of ongoing research and monitoring by health authorities and scientific experts. It’s important to note that the benefits of COVID-19 vaccination in preventing severe illness, hospitalization, and death far outweigh the risks of potential adverse effects. COVID-19 itself can have severe and long-lasting consequences, making vaccination a critical tool in controlling the pandemic.

Methods for Removing Spike Proteins

Natural Immune Response

The human immune system is a formidable defense mechanism against viral invaders. Both individuals who have recovered from COVID-19 and those who have been vaccinated will typically experience a gradual reduction in spike protein levels as their immune systems work tirelessly to clear the virus or vaccine remnants from the body.

Hydration and Detoxification

A well-hydrated body supports natural detoxification processes, potentially aiding in the removal of spike proteins. Drinking an ample amount of water can help flush out waste products and support the immune system’s efforts.

Antioxidant-Rich Diet

Nutrition plays a vital role in overall health and can potentially aid the body to remove spike protein. A diet rich in antioxidants from fruits and vegetables can help combat oxidative stress induced by viral infections.

Exercise and Sweating

Regular physical activity and sweating contribute to the removal of waste products from the body. Engaging in exercise may support the body’s natural cleansing mechanisms, potentially assisting in the removal of spike proteins.

Medications

In certain cases, healthcare providers may prescribe medications to manage specific symptoms of COVID-19 or to support the body’s immune response. However, there is currently no medication specifically designed to target or remove spike proteins.

Time

Patience is often key when it comes to removing spike protein from the body. Over time, the body’s immune system is generally effective at clearing spike proteins from the system. It is crucial to follow medical advice and treatment guidelines if you are infected with COVID-19 or have received the vaccine.

Conclusion

In conclusion, the question of “how to remove spike protein” underscores the significance of ongoing scientific research and medical advancements in the fight against infectious diseases. Spike proteins, while integral to the SARS-CoV-2 virus, can be managed by supporting the body’s immune system and practicing good overall health habits. By doing so, you can contribute to your body’s ability to fight off infections and maintain well-being. Consulting healthcare professionals for guidance on managing COVID-19 symptoms and following recommended vaccination guidelines remains paramount. Remember that time is often the most effective means of clearing spike proteins from the body.

References

Amundson, D. E., Shah, U. S., de Necochea-Campion, R., Jacobs, M., LaRosa, S. P., & Fisher Jr, C. J. (2021). Removal of COVID-19 spike protein, whole virus, exosomes, and exosomal MicroRNAs by the Hemopurifier® lectin-affinity cartridge in critically Ill patients with COVID-19 infection. Frontiers in Medicine, 8, 1763.

Halma, M. T., Plothe, C., Marik, P., & Lawrie, T. A. (2023). Strategies for the Management of Spike Protein-Related Pathology. Microorganisms, 11(5), 1308.